Intra-Cellular Therapies, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/19/2025

Shares

284,371

Value ($000)

37,514

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/19/2025	37,514	0.0%	284,371	3/31/2025
2024 Q4	2/14/2025	28,006	0.0%	335,319	12/31/2024
2024 Q3	11/14/2024	23,649	0.0%	323,208	9/30/2024
2024 Q2	8/14/2024	21,376	0.0%	312,104	6/30/2024
2024 Q1	5/15/2024	15,979	0.0%	230,910	3/31/2024
2023 Q4	2/14/2024	15,347	0.0%	214,281	12/31/2023
2023 Q3	11/13/2023	10,936	0.0%	209,935	9/30/2023
2023 Q2	8/11/2023	11,118	0.0%	205,312	6/30/2023
2023 Q1	5/15/2023	11,118	0.0%	205,312	3/31/2023
2022 Q4	2/14/2023	10,622	0.0%	200,713	12/31/2022
2022 Q3	11/14/2022	8,647	0.0%	185,832	9/30/2022
2022 Q2	8/12/2022	13,785	0.0%	241,501	6/30/2022
2022 Q1	5/16/2022	15,128	0.0%	247,234	3/31/2022
2021 Q4	2/14/2022	3,831	0.0%	73,196	12/31/2021
2021 Q3	11/15/2021	3,122	0.0%	83,746	9/30/2021
2021 Q2	8/16/2021	3,262	0.0%	79,901	6/30/2021
2021 Q1	5/14/2021	2,280	0.0%	67,208	3/31/2021
2020 Q4	3/1/2021	2,151	0.0%	67,644	12/31/2020
2020 Q3	11/13/2020	1,327	0.0%	51,702	9/30/2020
2020 Q2	8/14/2020	1,196	0.0%	46,588	6/30/2020
2020 Q1	5/15/2020	715	0.0%	46,543	3/31/2020
2019 Q4	2/14/2020	1,325	0.0%	38,613	12/31/2019